Pharmafile Logo
Pharmafocus logo
Advanced Search

Genentech shares data from phase 3 trials of Vabysmo for retinal vein occlusion treatment

October 10, 2023
Research and Development Genentech, Opthalmology, Vabysmo, phase 3 trial, retinal vein occlusion

Genentech has announced positive topline long-term results from its global phase 3 BALATON and COMINO trials which assessed extended treatment …

News

First patient dosed in Transgene and BioInvent’s phase 1 trial

October 10, 2023
Research and Development BioInvent, Oncology, Transgene, oncology, phase 1 trial

Transgene and BioInvent have announced that the first patient has been treated in the phase 1 part B clinical trial …

News

BMS acquires Mirati Therapeutics for $4.8bn

October 9, 2023
Business Services BMS, Mirati Therapeutics, Oncology, acquisition, bristol myers squibb, oncology

Bristol Myers Squibb (BMS) and Mirati Therapeutics have announced that they have entered into a definitive agreement under which BMS …

News

GSK and Zhifei partner for shingles vaccine promotion in China

October 9, 2023
Medical Communications GSK, Immunology, Shingrix, Vaccine, Zhifei, shingles

GSK has announced that it has come to an exclusive agreement with Chingqing Zhifei Biological Products to co-promote GSK’s shingles …

News

Sanofi shares new data for long-term efficacy of Nexviazyme for Pompe disease treatment

October 6, 2023
Research and Development Nexviazyme, Pharmacy, Pompe disease, Sanofi

Sanofi has shared new data for the long-term efficacy of Nexviazyme (avalglucosidease alfa) for the treatment of Pompe disease at …

News

FDA accepts Sun Pharma’s NDA for deuruxolitinib

October 6, 2023
Medical Communications Dermatology, FDA, NDA, SUun Pharma, deuruxolitinib

India-based pharma company Sun Pharmaceutical Industries has announced that the US Food and Drug Administration (FDA) has accepted its New …

News

FUJIFILM Diosynth Biotechnologies appoints Maja Pedersen as chief quality officer

October 6, 2023
Business Services Fujifilm, Fujifilm Diosynth Biotechnologies, Maja Pedersen, Pharmacy, appointment, chief quality officer

CEO and president of FUJIFULM Diosynth Biotechnologies Lars Petersen has appointed Maja Pedersen as chief quality officer, where she will …

Appointment

Janssen and Sanofi enter agreement for potential vaccine programme

October 5, 2023
Business Services Immunology, Janssen, Sanofi, e coli, vaccines

Janssen Pharmaceuticals, a Johnson & Johnson company, has announced a development and commercialisation agreement with Sanofi for Janssen’s extraintestinal pathogenic …

News
diana-polekhina-zbsthwt9vlc-unsplash_2

Moderna shares data from phase 1/2 trial for combination flu and COVID-19 vaccine

October 5, 2023
Research and Development COVID-19, Immunology, Moderna, clinical trial, influenza, vaccines

Moderna has announced positive interim results from the phase 1/2 trial of mRNA-1083, its investigational combination vaccine against influenza and …

News
louis-reed-pwckf7l4-no-unsplash_5

Sanofi and Teva partner for development of inflammatory bowel disease treatment

October 4, 2023
Medical Communications Crohn’s disease, Gastrointestinal tract, Sanofi, Teva, bowel disease, ulcerative colitis

Sanofi and Teva Pharmaceuticals have announced that they will collaborate for the co-development and co-commercialisation of TEV’574, a treatment for …

News

Eli Lilly to acquire POINT Biopharma

October 4, 2023
Business Services Eli Lilly, Oncology, POINT Biopharma, acquisition, oncology

Eli Lilly and POINT Biopharma have announced a definitive agreement for Lilly to acquire POINT to expand its pipeline of …

News

Acurx Pharmaceuticals announces positive data from phase 2b trial for C. difficile infection treatment

October 3, 2023
Research and Development Acurx Pharmaceuticals, C. difficile, Infections and infestations, clinical trial, infection

Acurx Pharmaceuticals has announced that it has discontinued its phase 2b clinical trial of its lead antibiotic candidate, ibezapolstat, for …

News

WHO recommends new vaccine for prevention of malaria in children

October 3, 2023
Medical Communications Immunology, Vaccine, WHO, malaria, malaria vaccine

The World Health Organization (WHO) has announced that it has recommended a new vaccine, R21/Matrix-M, for the prevention of malaria …

News

FDA grants marketing authorisation to DNA test for predisposition to certain cancers

October 2, 2023
Research and Development FDA, Invitae, Oncology, cancer testing, oncology

The US Food and Drug Administration (FDA) has granted de novo marketing authorisation to the Invitae Common Hereditary Cancers Panel, …

News

Biogen’s biosimilar Tofidence approved by FDA

October 2, 2023
Medical Communications Actemra, Biogen, FDA, Musculo-skeletal disorder, Tofidence

Biogen has announced that the US Food and Drug Administration (FDA) has approved Tofidence (tocilizumab-bavi) as an intravenous formulation, a …

News

Austrian state secretary to speak at FlyPharma Europe 2023

September 29, 2023
Business Services FlyPharma 2023, Vienna, flypharma

29 September 2023 — London, UK — FlyPharma Europe will welcome Mr Florian Tursky, the Austrian state secretary, to the …

News
Press release
robina-weermeijer-so1l3jsdd3y-unsplash_2

Karuna Therapeutics submits NDA to FDA for schizophrenia treatment

September 29, 2023
Medical Communications FDA, Karuna Therapeutics, Neurology, mental health, schizophrenia

Karuna Therapeutics has announced that it has submitted a New Drug Application (NDA) to the US Food and Drug Administration …

News

Kura Oncology shares preclinical data for NSCLC treatment

September 29, 2023
Medical Communications Kura Oncology, NSCLC, Oncology, oncology

Kura Oncology has shared positive preclinical data which supports the development of its next-generation farnesyl transferase inhibitor (FTI) KO-2806 in …

News

BactiVac funds development of bacterial vaccines to prevent infections against antimicrobial resistance

September 28, 2023
Research and Development AMR, BactiVac, Immunology, vaccines

The University of Birmingham hosted Bacterial Vaccines Network has been awarded £1.4m in funding from the UK government to accelerate …

News

Avalyn Pharma raises $175m in Series C financing for inhalation therapies

September 28, 2023
Business Services Avalyn Pharma, Financing, Pharmacy, funding, inhalation therapies

US-based clinical stage biopharmaceutical company Avalyn Pharma has announced that it has raised $175m in Series C financing to continue …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025